Searchable abstracts of presentations at key conferences in endocrinology

ea0016p224 | Diabetes and cardiovascular diseases | ECE2008

Atorvastatin ameliorates penile erection and sildenafil responsiveness in two distinct animal models of chemical diabetes and inhibits high glucose-induced alterations in human penile smooth muscle cells

Morelli Annamaria , Filippi Sandra , Vignozzi Linda , Zhang Xin-Hua , Mancina Rosa , Fibbi Benedetta , Chavalmane Aravinda , Silvestrini Enrico , Maggi Mario

One of the proposed mechanisms responsible for Diabetes mellitus (DM)-associated erectile (ED) dysfunction is overactivity of RhoA/ROCK signalling. Because statins may decrease RhoA activation, we investigated whether atorvastatin ameliorated DM-induced ED in alloxan-treated (100 mg/kg) rabbits (in vitro studies) and streptozotocin-treated (STZ, 50 mg/kg) rats (in vivo studies). A subgroup of diabetic animals received atorvastatin 5 mg/kg per daily 2 weeks before...

ea0016p402 | Neuroendocrinology | ECE2008

Effect of hyperprolactinemia in male patients consulting for sexual dysfunction

Giovanni Corona , Mannuci Edoardo , Fisher Alessandra , Lotti Francesco , Ricca Valdo , Balercia Giancarlo , Petrone Luisa , Forti Gianni , Maggi Mario

Objectives: The physiological role of prolactin in male sexual function has not been completely clarified. Aim of this study is the assessment of clinical features and of conditions associated with hyperprolactinemia in male patients consulting for sexual dysfunction.Design and methods: A consecutive series of 2146 (mean age 52.2±12.8 years) male patients with sexual dysfunction was studied. Several hormonal and biochemical parameters were studied a...

ea0016p508 | Obesity | ECE2008

NCEP-ATP-III defined metabolic syndrome, type 2 diabetes mellitus and prevalence of hypogonadism in male patients with sexual dysfunction

Corona Giovanni , Mannucci Edoardo , Petrone Luisa , Balercia Giancarlo , Paggi Federica , Fisher Alessandra , Lotti Francesco , Chiarini Valerio , Forti Gianni , Maggi Mario

Objectives: Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are characterized by insulin resistance and often associated with male hypogonadism. To discriminate the specific contribution of T2DM and MetS to male hypogonadism.Design and methods: A consecutive series of 1134 (mean age 52.1±13 years) male patients with sexual dysfunction was studied. Several hormonal and biochemical parameters were studied along with ANDROTEST, a 12-item ...

ea0016p628 | Reproduction | ECE2008

Bilateral cavernous neurotomy induces hypogonadotropic hypogonadism in rat: effect of testosterone and tadalafil supplementation

Filippi Sandra , Morelli Annamaria , Vignozzi Linda , Mancina Rosa , Silvestrini Enrico , Chavalmane Aravinda , Marini Mirca , Vannelli Gabriella Barbara , Maggi Mario

A previous study demonstrate that chronic tadalafil administration (2 mg/kg per day) was able to prevent some, but not all, penile alterations induced by long-term (3 months) bilateral cavernous neurotomy (BCN) in the rat. In particular, in vitro acetylcholine responsiveness and reduced eNOS and nNOS expression were not preserved, while PDE5 down-regulation, along with muscle/fiber ratio and hypoxygenation (hypoxyprobe) were significantly restored by chronic tadalafil (...

ea0014oc7.5 | Reproductive endocrinology I | ECE2007

Estrogens regulate epididymal contractility through RhoA/Rho-kinase signaling

Filippi Sandra , Morelli Annamaria , Vignozzi Linda , Mancina Rosa , Mungai Sara , Ambrosini Stefano , Vannelli Gabriella Barbara , Forti Gianni , Maggi Mario

Epididymis (epi) is a sex steroid-sensitive duct provided with spontaneous motility, allowing sperm transport. We previously demonstrated that human epi expresses a high abundance of mRNA for ER-alpha and ER-beta. We demonstrated that in epi estrogens up-regulate either oxytocin (OT) responsiveness, acting at the receptor level, and responsiveness to endothelin-1 (ET-1), another well-known stimulator of epididymal motility. However, we did not find any significant change eithe...

ea0014oc8.4 | Neuroendocrinology clinical | ECE2007

Idiopathic central hypothyroidism: report of a human natural model of congenital TRH receptor (TRHR) absence

Bonomi Marco , Busnelli Marta , Pilotta Alba , Prandi Elena , Maggi Mario , Buzi Fabio , Beck-Peccoz Paolo , Persani Luca

Central Hypothyroidism (CeH) is a rare thyroid hormone production defect due to an insufficient stimulation of a normal thyroid gland. Candidate genes for isolated CeH include TSHβ (several cases reported) and TRHR (only one case reported so far). Here, we report the clinical and genetic studies in 2 males and 3 females affected with isolated CeH with normal/low TSH levels (0.05–0.95 mU/L) and low FT4 levels (3.6–4.6 pM). None of the patients was detected at neo...

ea0014p194 | (1) | ECE2007

A comparison of NCEP-ATP-III and IDF metabolic syndrome definitions with relation to metabolic syndrome associated sexual dysfunction

Corona Giovanni , Mannucci Edoardo , Petrone Luisa , Lotti Francesco , Fisher Alessandra D , Balercia Giancarlo , Chairini Valerio , Forti Gianni , Maggi Mario

Objectives: The aim of present study was to verify possible differences in the prevalence of vasculogenic ED and hypogonadism comparing two distinct new definitions of MetS, as National Cholesterol Education Program-Third Adult Treatment Panel (NCEP-ATPIII) and International diabetes Federation (IDF) in patients with sexual dysfunction.Methods: Several hormonal, biochemical and instrumental (penile doppler ultrasound) parameters were studied. ANDROTEST S...

ea0014p611 | (1) | ECE2007

Androtest: a structured interview for the screening of hypogonadism in patients with sexual dysfunction

Corona Giovanni , Petrone Luisa , Mannucci Edoardo , Fisher Alessandra D , Chairini Valerio , Balercia Giancarlo , Forti Gianni , Maggi Mario

Objectives: Detecting hypogonadism is crucial in patients with sexual dysfunctions because hypogonadism can have a causal role for them and testosterone (T) substitution represents a milestone for the therapy. At present, three different inventories have been developed for screening of hypogonadism in aging male. All these instruments demonstrated a good sensitivity but low specificity. No inventories are available for the screening of hypogonadism in patients with sexual dysf...

ea0014p612 | (1) | ECE2007

Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction

Corona Giovanni , Petrone Luisa , Mannucci Edoardo , Magini Angela , Lotti Francesco , Ricca Valdo , Chiarini Valerio , Forti Gianni , Maggi Mario

Objectives: To date it is not clear to which extent a clinical, or even a subclinical, sexual dysfunction in the female partner might associate with erectile dysfunction (ED) in the male partner. The present study is aimed at the assessment of clinical features of ED associated with relational disturbances.Methods: In a consecutive series of 1140 male subjects reporting a stable couple relationship we evaluated the impact of relational factors, as assess...

ea0073pep11.1 | Presented ePosters 11: Adrenal and Cardiovascular Endocrinology | ECE2021

Fascin-1, a novel-circulating marker for the prognosis of the metastatic adrenocortical carcinoma

Cantini Giulia , Canu Letizia , De Filpo Giuseppina , Ercolino Tonino , Fei Laura , Nesi Gabriella , Maggi Mario , Mannelli Massimo , Luconi Michaela

Fascin-1(FSCN1) is an actin-bundling protein expressed in several solid carcinomas and often associated to an invasive and aggressive phenotype as it is involved in cytoskeleton rearrangement and filopodia formation. Adrenocortical carcinoma (ACC) is a rare endocrine malignancy characterized by a poor prognosis, particularly when metastatic at diagnosis. Complete surgical resection of the tumor mass is the main therapy for ACC patients in addition to the adjuvant administratio...